Patent details

Herbas

VPB

Print

EN | LT

Supplementary protection

LT - Hepatito C viruso inhibitoriai

EN - HEPATITIS C VIRUS INHIBITORS

SPC
(11)	Number of the document	C 2049522
(68)	Number of the document	2049522
(21)	Application number for Supplementary Protection Certificate	PA 2015 006
(22)	Date of filing the application	2015-02-03
(41)	Date of publication of the application	2015-03-25
	Date of publication of SPC	2016-12-27
(24)	Date of coming into effect of SPC	2027-08-10

Applicant
(71)	Bristol-Myers Squibb Holdings Ireland, ,

Grantee
(73)	Bristol-Myers Squibb Holdings Ireland Unlimited Company, Hinterbergstrasse 16, 6312 Steinhausen, CH

Attorney or representative
(74)	Tatjana STERLINA, UAB "Intels", Naugarduko g. 32/2, LT-03225 Vilnius, LT

Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93)	EU/1/14/939/001 - EU/1/14/939/004, 2, 0014-08-22

Calculated date of expiry of the SPC
(94)	2029-08-26

Name of the product protected by the basic patent
(95)	Daklatasviras ir jo farmaciniu požiūriu priimtinos druskos, ypač daklatasviro hidrochloridas

Legal status
	SPC lapsed (non-payment of fees for the main patent)
	Date of negative decision to issue the SPC	2020-08-09